SGAM
Smith Group Asset Management’s Corcept Therapeutics CORT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $662K | Hold |
9,019
| – | – | 0.04% | 114 |
|
2025
Q1 | $1.03M | Sell |
9,019
-6,389
| -41% | -$730K | 0.08% | 84 |
|
2024
Q4 | $776K | Buy |
15,408
+152
| +1% | +$7.66K | 0.06% | 101 |
|
2024
Q3 | $706K | Buy |
15,256
+3,081
| +25% | +$143K | 0.06% | 80 |
|
2024
Q2 | $396K | Buy |
12,175
+73
| +0.6% | +$2.37K | 0.04% | 100 |
|
2024
Q1 | $305K | Hold |
12,102
| – | – | 0.02% | 170 |
|
2023
Q4 | $393K | Buy |
+12,102
| New | +$393K | 0.02% | 142 |
|
2021
Q4 | – | Sell |
-27,422
| Closed | -$540K | – | 373 |
|
2021
Q3 | $540K | Sell |
27,422
-1,458
| -5% | -$28.7K | 0.03% | 128 |
|
2021
Q2 | $635K | Sell |
28,880
-265
| -0.9% | -$5.83K | 0.03% | 118 |
|
2021
Q1 | $693K | Sell |
29,145
-31,660
| -52% | -$753K | 0.04% | 97 |
|
2020
Q4 | $1.59M | Sell |
60,805
-9,270
| -13% | -$243K | 0.09% | 90 |
|
2020
Q3 | $1.22M | Sell |
70,075
-6,450
| -8% | -$112K | 0.06% | 95 |
|
2020
Q2 | $1.29M | Buy |
76,525
+2,169
| +3% | +$36.5K | 0.07% | 93 |
|
2020
Q1 | $884K | Buy |
74,356
+36,920
| +99% | +$439K | 0.05% | 96 |
|
2019
Q4 | $453K | Buy |
+37,436
| New | +$453K | 0.02% | 154 |
|
2018
Q4 | – | Sell |
-37,505
| Closed | -$526K | – | 454 |
|
2018
Q3 | $526K | Sell |
37,505
-59,360
| -61% | -$833K | 0.02% | 198 |
|
2018
Q2 | $1.52M | Sell |
96,865
-57,280
| -37% | -$901K | 0.04% | 145 |
|
2018
Q1 | $2.54M | Sell |
154,145
-100,491
| -39% | -$1.65M | 0.08% | 108 |
|
2017
Q4 | $4.6M | Sell |
254,636
-11,449
| -4% | -$207K | 0.14% | 101 |
|
2017
Q3 | $5.14M | Buy |
266,085
+1,990
| +0.8% | +$38.4K | 0.17% | 92 |
|
2017
Q2 | $3.12M | Buy |
264,095
+177,955
| +207% | +$2.1M | 0.1% | 132 |
|
2017
Q1 | $944K | Sell |
86,140
-30
| -0% | -$329 | 0.03% | 173 |
|
2016
Q4 | $626K | Buy |
+86,170
| New | +$626K | 0.02% | 176 |
|
2016
Q3 | – | Sell |
-30,080
| Closed | -$164K | – | 462 |
|
2016
Q2 | $164K | Buy |
30,080
+12,300
| +69% | +$67.1K | ﹤0.01% | 280 |
|
2016
Q1 | $83K | Buy |
17,780
+4,210
| +31% | +$19.7K | ﹤0.01% | 281 |
|
2015
Q4 | $68K | Buy |
+13,570
| New | +$68K | ﹤0.01% | 312 |
|